Stockreport

Protalix BioTherapeutics to Announce Third Quarter 2024 Financial and Business Results on November 14, 2024

Protalix BioTherapeutics, Inc. (DE)  (PLX) 
PDF Company to host conference call and webcast at 8:30 a.m. ESTCARMIEL, Israel, Nov. 7, 2024 /PRNewswire/ -- Protalix BioTherapeutics, Inc. (NYSE American: PLX), a biopharm [Read more]